Immodulon Therapeutics Ltd
6 clinical trials · Sponsor
◉ Watch Immodulon Therapeutics Ltd
| Record | Firm | Date |
|---|---|---|
| A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma (NCT03711188) | Immodulon Therapeutics Ltd | 2018-10-04 |
Track Immodulon Therapeutics Ltd automatically
Every clearance here is in the API, with alerts when new ones post.